In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...